Канал: pharmaphorum media limited

Looking to history to prepare for America’s uncertain future

Looking to history to prepare for America’s uncertain future

Next gen wearables: Transforming remote patient care

Next gen wearables: Transforming remote patient care

From neurosurgery to focused ultrasound: Not if, but when

From neurosurgery to focused ultrasound: Not if, but when

Seeking a single source of truth: Standardisation of the data model

Seeking a single source of truth: Standardisation of the data model

A journey from personal to public: Digital health passports today

A journey from personal to public: Digital health passports today

Access to genomic surveillance: Open science and public health

Access to genomic surveillance: Open science and public health

LSX 2024 - Dr Tadaaki Taniguchi

LSX 2024 - Dr Tadaaki Taniguchi

ESMO 2024 – Dr Meredith McKean

ESMO 2024 – Dr Meredith McKean

ESMO 2024 – Magda Meissner

ESMO 2024 – Magda Meissner

LSX 2024 – James Graham, Recce Pharma

LSX 2024 – James Graham, Recce Pharma

Advancing Precision Care For All

Advancing Precision Care For All

ESMO 2024 - Daejin Abidoye

ESMO 2024 - Daejin Abidoye

LSX 2024 - Luba Greenwood and Hakim Yadi

LSX 2024 - Luba Greenwood and Hakim Yadi

Investment outlook: Key takeaways from LSX USA

Investment outlook: Key takeaways from LSX USA

Boehringer Ingelheim and Veeva: A data partnership for One Medicine

Boehringer Ingelheim and Veeva: A data partnership for One Medicine

ESMO 2024 - Henar Hevia & Carolyn Sousa

ESMO 2024 - Henar Hevia & Carolyn Sousa

ESMO 2024 - Israel (Izzy) Lowy

ESMO 2024 - Israel (Izzy) Lowy

Oncology today: Eversana and pharmaphorum at ESMO 2024

Oncology today: Eversana and pharmaphorum at ESMO 2024

Eversana and pharmaphorum in conversation: ESMO 2024

Eversana and pharmaphorum in conversation: ESMO 2024

ESMO 2024 - Sven Schaffer

ESMO 2024 - Sven Schaffer

Medicare drug pricing negotiations: What comes next?

Medicare drug pricing negotiations: What comes next?

The Life Sciences Generative AI Council and a sustainable technological future

The Life Sciences Generative AI Council and a sustainable technological future

Can self-navigating ADCs replace chemotherapy in the future?

Can self-navigating ADCs replace chemotherapy in the future?

Structuring the unstructured: Deterministic AI and white box data cleanliness

Structuring the unstructured: Deterministic AI and white box data cleanliness

People need to know how to use AI now

People need to know how to use AI now

Chronic cough and the patient voice

Chronic cough and the patient voice

Approaching the regulatory world with passion: CERs and EU MDR processes

Approaching the regulatory world with passion: CERs and EU MDR processes

Health Innovators - Steve Damon

Health Innovators - Steve Damon

Patient engagement throughout the product lifecycle

Patient engagement throughout the product lifecycle

ASCO 2024 - Matteo Levisetti

ASCO 2024 - Matteo Levisetti

The empowerment of data and predictive outcome models

The empowerment of data and predictive outcome models

In conversation with Chris Moore: Declining HCP access

In conversation with Chris Moore: Declining HCP access

The burden of diabetic vision loss in the West

The burden of diabetic vision loss in the West

Tips for on-time tech transfers that stay below budget

Tips for on-time tech transfers that stay below budget

ASCO 2024 - Steve Devine

ASCO 2024 - Steve Devine

Clinical trial trends and the rise of site networks

Clinical trial trends and the rise of site networks

ASCO 2024 - Chris Haqq

ASCO 2024 - Chris Haqq

A spectrum of obesity requires precision

A spectrum of obesity requires precision

ASCO 2024 - Michael Petroutsas

ASCO 2024 - Michael Petroutsas

ASCO 2024 - Andree Amelsberg

ASCO 2024 - Andree Amelsberg

The power and potential of regenerative medicine

The power and potential of regenerative medicine

Veeva R&D and Quality 2024: Chris Moore

Veeva R&D and Quality 2024: Chris Moore

ASCO 2024 – Thanos Zomas

ASCO 2024 – Thanos Zomas

Leveraging data and AI for clinical trial success

Leveraging data and AI for clinical trial success

ASCO 2024 - Warner Biddle and Ibrahim Elhoussieny

ASCO 2024 - Warner Biddle and Ibrahim Elhoussieny

The future of fertility and the vaginal microbiome

The future of fertility and the vaginal microbiome

Sustainable innovation for patients, people, and planet

Sustainable innovation for patients, people, and planet

ASCO 2024 - Scot Ebbinghaus

ASCO 2024 - Scot Ebbinghaus

ASCO 2024 - Henar Hevia and Carolyn Sousa

ASCO 2024 - Henar Hevia and Carolyn Sousa

The new frontier of microbiome-directed human health

The new frontier of microbiome-directed human health

ASCO 2024 - Paul Burton

ASCO 2024 - Paul Burton

Global medicines and the future outlook

Global medicines and the future outlook

Purity, potency, and safety – affordably – in stem cell therapy

Purity, potency, and safety – affordably – in stem cell therapy

ASCO 2024 - Suzanne Trudel

ASCO 2024 - Suzanne Trudel

The art of software

The art of software

ASCO 2024 - Mohit Manrao

ASCO 2024 - Mohit Manrao

Move over CAR-T: The potential of NK cells in cell therapy

Move over CAR-T: The potential of NK cells in cell therapy

Working for a mature form of genomic medicines

Working for a mature form of genomic medicines

Challenges and opportunities in synthetic clinical trials

Challenges and opportunities in synthetic clinical trials

The commercialisation of quantum science in pharma

The commercialisation of quantum science in pharma

Conference report: Reuters Pharma Europe

Conference report: Reuters Pharma Europe

In vitro gametogenesis: the science has to be right, and it has to be safe

In vitro gametogenesis: the science has to be right, and it has to be safe

Reuters Pharma Sandoz Peter Stenico EU24

Reuters Pharma Sandoz Peter Stenico EU24

Proving ROI for digital endpoints

Proving ROI for digital endpoints

Clinical trials: their design, location, and, potentially, their simulation

Clinical trials: their design, location, and, potentially, their simulation

Pace, acceleration, and precision are the name of the game

Pace, acceleration, and precision are the name of the game

Technology working as the puzzle piece to bring better outcomes to patients

Technology working as the puzzle piece to bring better outcomes to patients

Reuters Pharma USA 2024 – Moreno Perugini

Reuters Pharma USA 2024 – Moreno Perugini

Is precision psychiatry possible?

Is precision psychiatry possible?

Encouraging early engagement to revitalise Europe’s pharmaceutical landscape

Encouraging early engagement to revitalise Europe’s pharmaceutical landscape

Reuters Pharma USA 2024 – Serena Goodwin

Reuters Pharma USA 2024 – Serena Goodwin

Predictions for AI in mental health in the coming year

Predictions for AI in mental health in the coming year

Reuters Pharma USA 2024 – Nick Altebrando and Shireen Saxena

Reuters Pharma USA 2024 – Nick Altebrando and Shireen Saxena

Reuters Pharma USA 2024 – Lung-I Cheng

Reuters Pharma USA 2024 – Lung-I Cheng

Fixing clinical trial data management

Fixing clinical trial data management

Reuters Pharma USA 2024 – Jeffrey Meckler

Reuters Pharma USA 2024 – Jeffrey Meckler

Harnessing the velocity of biopharmaceutical advances

Harnessing the velocity of biopharmaceutical advances

Reuters Pharma USA 2024 – Blair McNeill

Reuters Pharma USA 2024 – Blair McNeill

Conference report: Reuters Pharma USA

Conference report: Reuters Pharma USA

Reuters Pharma USA 2024 – Mindy McGrath

Reuters Pharma USA 2024 – Mindy McGrath

The future of AI: Machine learning working together with scientific expertise

The future of AI: Machine learning working together with scientific expertise

Understanding the politics of drug pricing in the United States

Understanding the politics of drug pricing in the United States

Female leadership and lessening disease burden

Female leadership and lessening disease burden

Health Innovators Pierre Luzeau

Health Innovators Pierre Luzeau

The unique clinical trial challenges faced by digital therapeutics

The unique clinical trial challenges faced by digital therapeutics

The unmentionables: Challenging inequalities in women’s health

The unmentionables: Challenging inequalities in women’s health

The next chapter for AI protein structure prediction

The next chapter for AI protein structure prediction

Avoiding the data swamp: The transformative power of AI

Avoiding the data swamp: The transformative power of AI

How natural language processing can make a difference in pharma

How natural language processing can make a difference in pharma

Transitioning from traditional surgical methods to the innovative use of stem cells.

Transitioning from traditional surgical methods to the innovative use of stem cells.

The 2024 biopharma M&A landscape: An overview

The 2024 biopharma M&A landscape: An overview

Accelerating the process, transforming therapies and advancing precision medicine

Accelerating the process, transforming therapies and advancing precision medicine

Applying genetics to chemistry to find new small molecules

Applying genetics to chemistry to find new small molecules

JP Morgan 2024 – Sam Deutsch

JP Morgan 2024 – Sam Deutsch

Opening the digital front door to advanced healthcare

Opening the digital front door to advanced healthcare

JP Morgan 2024 – Xavier Duportet

JP Morgan 2024 – Xavier Duportet

Pharmaceutical research in space

Pharmaceutical research in space

JP Morgan 2024 – Marianne De Backer

JP Morgan 2024 – Marianne De Backer

Precision medicine in mental health - one size really doesn’t fit all

Precision medicine in mental health - one size really doesn’t fit all

JP Morgan 2024 – Trevor Martin

JP Morgan 2024 – Trevor Martin

Where are the pharma voices in US politics?

Where are the pharma voices in US politics?

JP Morgan 2024 – Simon Arkell

JP Morgan 2024 – Simon Arkell

A clearer harmony and attractiveness for EU Clinical Trials Regulation

A clearer harmony and attractiveness for EU Clinical Trials Regulation

JP Morgan 2024 – Katherine Stueland

JP Morgan 2024 – Katherine Stueland

Making connections and getting noticed as a biotech start-up

Making connections and getting noticed as a biotech start-up

JP Morgan 2024 – Gene Kinney

JP Morgan 2024 – Gene Kinney

Getting down to the nitty gritty of actively creating healthier societies

Getting down to the nitty gritty of actively creating healthier societies

JP Morgan 2024 – Frank Gleeson

JP Morgan 2024 – Frank Gleeson

How manufacturing keeps pace with innovation in cell and gene therapy

How manufacturing keeps pace with innovation in cell and gene therapy

JP Morgan 2024 – Jen Nwankwo

JP Morgan 2024 – Jen Nwankwo

Fixing the inequity of drug access outside of the US

Fixing the inequity of drug access outside of the US

JP Morgan 2024 – Graham Heap

JP Morgan 2024 – Graham Heap

Key themes from JP Morgan

Key themes from JP Morgan

JP Morgan 2024 – Jeff Smith

JP Morgan 2024 – Jeff Smith

Prediction is very difficult, especially if it’s about the future

Prediction is very difficult, especially if it’s about the future

Veeva Chris Moore Interview

Veeva Chris Moore Interview

Promoting value-added medicines and renovating old medicines smartly

Promoting value-added medicines and renovating old medicines smartly

Digitisation of drug R&D: Avoiding new for novelty’s sake

Digitisation of drug R&D: Avoiding new for novelty’s sake

The problems of animal research for human medicine and the alternatives

The problems of animal research for human medicine and the alternatives

The race to develop innovative products and supply chain solutions

The race to develop innovative products and supply chain solutions

The smart-design evolution of the laboratory space

The smart-design evolution of the laboratory space

Investing in the gleams of positivity and hope for life sciences innovation

Investing in the gleams of positivity and hope for life sciences innovation

Looking to the future of UK medical device exports

Looking to the future of UK medical device exports

Exploring the reasons behind increasing burdens on clinical research sites

Exploring the reasons behind increasing burdens on clinical research sites

An investor’s perspective on bio and tech

An investor’s perspective on bio and tech

Why digital therapeutics (DTx) are effective and safe, but not being prescribed

Why digital therapeutics (DTx) are effective and safe, but not being prescribed

AI drug discovery: Where we are and where we’re going

AI drug discovery: Where we are and where we’re going

Retaining the human element in healthcare services whilst embracing the potential of robotics

Retaining the human element in healthcare services whilst embracing the potential of robotics

Bringing women’s health up to speed for 21st Century human healthcare

Bringing women’s health up to speed for 21st Century human healthcare

Creating a future where the healthcare ecosystem works for everyone

Creating a future where the healthcare ecosystem works for everyone

Key themes from Frontiers Health 2023, with the pharmaphorum team

Key themes from Frontiers Health 2023, with the pharmaphorum team

Reducing the stigma attached to psychedelics

Reducing the stigma attached to psychedelics

How birth tissue donations are fuelling the cell therapy revolution

How birth tissue donations are fuelling the cell therapy revolution

Immunometabolism: Providing a new era of targeted medicine

Immunometabolism: Providing a new era of targeted medicine

Frontiers Health 2023 Hakim Yadi Closed Loop Medicine

Frontiers Health 2023 Hakim Yadi Closed Loop Medicine

Retaining the human element of AI within pharma and healthcare

Retaining the human element of AI within pharma and healthcare

HealthInnovators Interview Aleks Engel

HealthInnovators Interview Aleks Engel

Resilience, empathy, and gratitude. A personal battle with breast cancer.

Resilience, empathy, and gratitude. A personal battle with breast cancer.

Jonathan Wofford CAR TCR 23

Jonathan Wofford CAR TCR 23

HealthInnovators Interview Søren Møller

HealthInnovators Interview Søren Møller

The ‘elegant science’ in achieving the promise of ADCs

The ‘elegant science’ in achieving the promise of ADCs

Mindy Miller CAR TCR 23

Mindy Miller CAR TCR 23

Understanding the importance of the whole person in clinical research

Understanding the importance of the whole person in clinical research

HealthInnovators Interview Thomas Carlsen

HealthInnovators Interview Thomas Carlsen

Matt Lakelin CAR-TCR 2023

Matt Lakelin CAR-TCR 2023

Why medical weight loss is more complicated than GLP-1s

Why medical weight loss is more complicated than GLP-1s

Health Innovators Interview Melissa Little

Health Innovators Interview Melissa Little

Creating behavioural change through incremental, small steps

Creating behavioural change through incremental, small steps

Tim McGuire CAR TCR 23

Tim McGuire CAR TCR 23

How AI can bolster each step of the clinical trial journey

How AI can bolster each step of the clinical trial journey

Focussing on finding value in health sciences marketing

Focussing on finding value in health sciences marketing

Dr Pamela Garzone CAR TCR 23

Dr Pamela Garzone CAR TCR 23

How big pharma cares for its own

How big pharma cares for its own

Embracing the challenges and opportunities of digital health

Embracing the challenges and opportunities of digital health

Josh Ludwig CAR TCR 23

Josh Ludwig CAR TCR 23

How AI and omnichannel are transforming pharma marketing

How AI and omnichannel are transforming pharma marketing

Digital therapeutics at a turning point: What we heard at DtX East

Digital therapeutics at a turning point: What we heard at DtX East

CAR-TCR 2023 – Becky Cap

CAR-TCR 2023 – Becky Cap

Understanding and addressing care disparities in rare cancers

Understanding and addressing care disparities in rare cancers

Jason Noon CAR TCR 23

Jason Noon CAR TCR 23

Turning drug development on its head

Turning drug development on its head

Greg Deener CAR TCR 23

Greg Deener CAR TCR 23

GLP-1 Weight loss drugs: An overview and update

GLP-1 Weight loss drugs: An overview and update

Biopharma’s rapid transition to omnichannel marketing

Biopharma’s rapid transition to omnichannel marketing

Health Innovators – Or Shoval and Shahar Shelly

Health Innovators – Or Shoval and Shahar Shelly

Partnering for holistic care

Partnering for holistic care

Health Innovators – Dr Jack Hoppin and Dr John Babich Ratio Therapeutics (Follow-up)

Health Innovators – Dr Jack Hoppin and Dr John Babich Ratio Therapeutics (Follow-up)

Mapping the landscape of clinical trial regulation

Mapping the landscape of clinical trial regulation

Preparing for the tsunami of healthcare data approaching

Preparing for the tsunami of healthcare data approaching

Alzheimer’s drugs: An overview and update

Alzheimer’s drugs: An overview and update

Suffering beyond physical effects: inequalities and taboos in prostate cancer

Suffering beyond physical effects: inequalities and taboos in prostate cancer

Collaborative perseverance to bring change to medicine access

Collaborative perseverance to bring change to medicine access

Botanicals in pharma: Potential and pitfalls

Botanicals in pharma: Potential and pitfalls

Clinical trial diversity: An update

Clinical trial diversity: An update

ASCO 2023 – Dr Lalan Wilfong

ASCO 2023 – Dr Lalan Wilfong

ASCO 2023 – Jaydev Thakkar

ASCO 2023 – Jaydev Thakkar

Changing personnel dynamics in the pharma world

Changing personnel dynamics in the pharma world

Retaining the human quality of healthcare in DTx

Retaining the human quality of healthcare in DTx

ASCO 2023 - Mark Reisenauer

ASCO 2023 - Mark Reisenauer

Focusing on predictability and execution in digital trials

Focusing on predictability and execution in digital trials

ASCO 2023 – Warner Biddle

ASCO 2023 – Warner Biddle

ASCO 2023 – Jennifer Elliott

ASCO 2023 – Jennifer Elliott

QuDoS Highlights 2023

QuDoS Highlights 2023

ASCO 2023 – Martin Vogel and Edmond Chan

ASCO 2023 – Martin Vogel and Edmond Chan

Genetic testing update with 23andMe’s Noura Abul-Husn

Genetic testing update with 23andMe’s Noura Abul-Husn

ASCO 2023 – Corina Dutcus

ASCO 2023 – Corina Dutcus

Headlines and hot topics from ASCO and BIO

Headlines and hot topics from ASCO and BIO

ASCO 2023 – Gregory Lubiniecki

ASCO 2023 – Gregory Lubiniecki

ASCO 2023 – Arun Krishna

ASCO 2023 – Arun Krishna

The precision element at the heart of digital transformation

The precision element at the heart of digital transformation

Health Innovators – Jennifer Schranz

Health Innovators – Jennifer Schranz

AI in drug development: A reality check

AI in drug development: A reality check

Epiphany moments in an industry starved of insights

Epiphany moments in an industry starved of insights

A closer look at gene therapy with PTC Therapeutics

A closer look at gene therapy with PTC Therapeutics

Health Innovators – Fady Malik and Steve Heitner

Health Innovators – Fady Malik and Steve Heitner

WWD: Ready, Set, Food! CEO, Daniel Zakowski

WWD: Ready, Set, Food! CEO, Daniel Zakowski

Reuters Pharma USA – Maria Whitman

Reuters Pharma USA – Maria Whitman

The Hidden Burden of Stigmatised Health Conditions

The Hidden Burden of Stigmatised Health Conditions

Creating healthier futures - Reuters Pharma Barcelona 2023

Creating healthier futures - Reuters Pharma Barcelona 2023

Reuters Pharma USA – Lung-I Cheng

Reuters Pharma USA – Lung-I Cheng